Suppr超能文献

过氧化物酶体 β-氧化调节全身代谢、炎症活力和非酒精性脂肪性肝病的发病机制。

Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.

机构信息

Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

Division of Immunobiology, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, USA.

出版信息

JCI Insight. 2018 Mar 22;3(6):93626. doi: 10.1172/jci.insight.93626.

Abstract

Nonalcoholic fatty liver disease (NAFLD), a metabolic predisposition for development of hepatocellular carcinoma (HCC), represents a disease spectrum ranging from steatosis to steatohepatitis to cirrhosis. Acox1, a rate-limiting enzyme in peroxisomal fatty acid β-oxidation, regulates metabolism, spontaneous hepatic steatosis, and hepatocellular damage over time. However, it is unknown whether Acox1 modulates inflammation relevant to NAFLD pathogenesis or if Acox1-associated metabolic and inflammatory derangements uncover and accelerate potential for NAFLD progression. Here, we show that mice with a point mutation in Acox1 (Acox1Lampe1) exhibited altered cellular metabolism, modified T cell polarization, and exacerbated immune cell inflammatory potential. Further, in context of a brief obesogenic diet stress, NAFLD progression associated with Acox1 mutation resulted in significantly accelerated and exacerbated hepatocellular damage via induction of profound histological changes in hepatocytes, hepatic inflammation, and robust upregulation of gene expression associated with HCC development. Collectively, these data demonstrate that β-oxidation links metabolism and immune responsiveness and that a better understanding of peroxisomal β-oxidation may allow for discovery of mechanisms central for NAFLD progression.

摘要

非酒精性脂肪性肝病 (NAFLD) 是肝细胞癌 (HCC) 发展的代谢倾向,代表了从脂肪变性到脂肪性肝炎再到肝硬化的疾病谱。过氧化物酶体脂肪酸β-氧化的限速酶 Acox1 调节代谢、自发性肝脂肪变性和随时间推移的肝细胞损伤。然而,尚不清楚 Acox1 是否调节与 NAFLD 发病机制相关的炎症,或者 Acox1 相关的代谢和炎症紊乱是否揭示并加速了 NAFLD 进展的潜力。在这里,我们表明,过氧化物酶体脂肪酸β-氧化的限速酶 Acox1 中的点突变 (Acox1Lampe1) 表现出改变的细胞代谢、改变的 T 细胞极化和加剧的免疫细胞炎症潜力。此外,在短暂的肥胖饮食应激下,与 Acox1 突变相关的 NAFLD 进展导致通过诱导肝细胞、肝炎症和与 HCC 发展相关的基因表达的显著增加的深刻组织学变化,显著加速和加剧肝细胞损伤。总的来说,这些数据表明β-氧化将代谢和免疫反应联系起来,更好地理解过氧化物酶体β-氧化可能为发现 NAFLD 进展的核心机制提供线索。

相似文献

3
Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
Am J Physiol Endocrinol Metab. 2020 Nov 1;319(5):E863-E876. doi: 10.1152/ajpendo.00321.2020. Epub 2020 Sep 14.
4
NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.
Nature. 2016 Mar 10;531(7593):253-7. doi: 10.1038/nature16969. Epub 2016 Mar 2.
7
Autophagy, NAFLD and NAFLD-Related HCC.
Adv Exp Med Biol. 2018;1061:127-138. doi: 10.1007/978-981-10-8684-7_10.
8
Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
9
miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes.
Hepatobiliary Pancreat Dis Int. 2019 Aug;18(4):360-365. doi: 10.1016/j.hbpd.2019.05.002. Epub 2019 May 13.

引用本文的文献

1
Peroxisome Dysfunction and Steatotic Liver Disease.
Int J Mol Sci. 2025 Aug 27;26(17):8303. doi: 10.3390/ijms26178303.
3
Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy.
Genes (Basel). 2025 May 17;16(5):590. doi: 10.3390/genes16050590.
5
Total glucosides of Picrorhizae Rhizome alleviate non-alcoholic steatohepatitis (NASH) by specifically targeting acyl-CoA oxidase 1.
Heliyon. 2024 Oct 26;10(21):e39874. doi: 10.1016/j.heliyon.2024.e39874. eCollection 2024 Nov 15.
6
Regulation of Mitochondrial and Peroxisomal Metabolism in Female Obesity and Type 2 Diabetes.
Int J Mol Sci. 2024 Oct 19;25(20):11237. doi: 10.3390/ijms252011237.
7
Genome-Wide Analysis Reveals Copy Number Variant Gene Regulates Pig Back Fat Deposition.
Animals (Basel). 2024 Sep 12;14(18):2657. doi: 10.3390/ani14182657.
10
Essential phospholipids impact cytokine secretion and alter lipid-metabolizing enzymes in human hepatocyte cell lines.
Pharmacol Rep. 2024 Jun;76(3):572-584. doi: 10.1007/s43440-024-00595-4. Epub 2024 Apr 26.

本文引用的文献

2
Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma.
Cancer Cell. 2016 Jul 11;30(1):161-175. doi: 10.1016/j.ccell.2016.05.020.
3
Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
Mol Metab. 2016 Feb 2;5(4):283-295. doi: 10.1016/j.molmet.2016.01.010. eCollection 2016 Apr.
4
Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.
PLoS One. 2016 Feb 19;11(2):e0149783. doi: 10.1371/journal.pone.0149783. eCollection 2016.
5
Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity.
Cell. 2015 Dec 3;163(6):1400-12. doi: 10.1016/j.cell.2015.11.009. Epub 2015 Nov 19.
7
Hepatic TLR4 signaling in obese NAFLD.
Am J Physiol Gastrointest Liver Physiol. 2015 Aug 15;309(4):G270-8. doi: 10.1152/ajpgi.00304.2014. Epub 2015 Jun 25.
8
IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression.
Curr Drug Targets. 2015;16(12):1315-23. doi: 10.2174/1389450116666150531153627.
9
Identification of Lipid Species Linked to the Progression of Non-Alcoholic Fatty Liver Disease.
Curr Drug Targets. 2015;16(12):1293-300. doi: 10.2174/1389450116666150408103318.
10
Thermoneutral housing is a critical factor for immune function and diet-induced obesity in C57BL/6 nude mice.
Int J Obes (Lond). 2015 May;39(5):791-7. doi: 10.1038/ijo.2014.187. Epub 2014 Oct 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验